Wenshi Wang

SVP Tech & Ops at FosunKairos

Speaker

Wenshi received her MD of clinical medicine from Tianjin Medical University and her master and PhD on immunology and microbiology from Tianjin Medical University and Tongji Medical College of Huazhong Science & Technology University & Heidelberg University.

Wenshi’s work experience focuses on immune-oncology and cell therapy. Wenshi conducted her post-doc and research scientist training in City of Hope, University of Southern California (USC) and Moffitt Cancer Center.

Her experience of biotech and biopharma is CGT driven (Hemacare, Kite Pharma, Sangamo Therapeutics and Metagenomi). Wen­shi Wang brings both inter­na­tion­al and Amer­i­can insti­tu­tion­al drug devel­op­ment expe­ri­ence to her role at FosunKairos. She serves as SVP tech & Ops.

She has made sig­nif­i­cant con­tri­bu­tions to many suc­cess­ful fil­ings with agen­cies (Inter­act, Pre-IND, IND/IMPD, Pre-BLA, NDA). Wenshi has published multiple research articles and patents.